Another PPARγ synthetic ligand, ciglitazone, produces a rapid dose-dependent loss of mitochondrial membrane potential, along with a rapid overproduction of reactive oxygen species (ROS) in rat glioma cells [5]. Here, PPARG is linked to central nervous system cancer.